← Eichor
Study identifier: NCT06889974 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome

Condition: Renal Replacement Therapy for Acute Kidney Injury in ICU  ·  Sponsor: University Hospital, Bordeaux

PhaseN/A
Planned participants800
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The TENDERS study aims to evaluate the impact of the timing of renal replacement therapy (RRT) initiation on outcomes in patients with tumor lysis syndrome (TLS) and associated acute kidney injury (AKI). The study will compare early versus delayed RRT initiation, examining the effect on renal function at 30 days post-treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Arthur ORIEUX  ·  05 56 70 56 79  ·  arthur.orieux@chu-bordeaux.fr

Always discuss trial participation with your own doctor first.

Locations (10)

CHU d'AngersAngers, FranceWithdrawn
Hôpital PellegrinBordeaux, FranceRecruiting
Hôpital la cavale blancheBrest, FranceRecruiting
CHU Dupuytren 1Limoges, FranceWithdrawn
Hôtel-DieuNantes, FranceRecruiting
CHR d'OrléansOrléans, FranceRecruiting
CH de PauPau, FranceRecruiting
Centre Urgences-RéanimationsRennes, FranceRecruiting
IUCT-O Hopital PurpanToulouse, FranceRecruiting
Hôpital BretonneauTours, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06889974